ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breast-feeding. There aren't enough data regarding how exposure over time may affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological disorders such as impaired vision or hearing seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications need to balance the benefits of taking them against the potential risks to the fetus. Physicians do not have the data needed to give clear guidelines, but they can provide information on risks and benefits that help pregnant women make informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy were not at greater risk of fetal malformations, or structural birth defects. Researchers conducted a large population-based study of case-control to assess the risk of major structural birth defects in babies born to mothers who had taken stimulants in early pregnancy, and those who did not. Clinical geneticists, pediatric cardiologists and other experts reviewed the cases in order to confirm that the classification was accurate and to reduce any bias.

However, the researchers' study was not without its flaws. The researchers were not able to, in the first place, to separate the effects triggered by the medication from the disorder. This makes it difficult to know whether the limited associations observed in the exposed groups result from medication use or comorbidities that cause confusion. Additionally the researchers did not study the long-term effects of offspring on their parents.

The study did reveal that infants whose mothers took ADHD medications during pregnancy were at a slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than those whose mothers had not taken any medication or cut back on their medications prior to or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not influenced by the stimulant medication used during pregnancy.

Women who used stimulant ADHD medication during pregnancy were also at an increased risk of having a caesarean section or having a baby born with an low Apgar score (less than 7). These risks did not appear to be influenced by the type of medication that was used during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefit for both mother and child of continued treatment for the woman's condition. Physicians should speak with their patients about this and, if possible, help them develop coping skills that could reduce the effects of her disorder on her daily functioning and her relationships.

Interactions with Medication

As more women than ever are diagnosed with ADHD and treated with medication, the dilemma of whether to continue or stop treatment during pregnancy is a question that more and more doctors confront. Often, these decisions are taken in the absence of any evidence that is clear and definitive regardless, so doctors must weigh what they know about their experiences, the experiences of other doctors, and what the research says on the topic as well as their best judgment for each individual patient.

Particularly, the issue of possible risks to the baby can be a challenge. Many studies on this issue are based on observations rather than controlled research, and their findings are often contradictory. Additionally, the majority of studies limit their analysis to live births, which could underestimate severe teratogenic effects that result in abortion or termination of the pregnancy. The study discussed in this journal club addresses these limitations by looking at data from both live and deceased births.

The conclusion: While some studies have shown an association between ADHD medications and the risk of certain birth defects, others have found no such relationship, and most studies have a neutral or slightly negative effect. Therefore, a careful risk/benefit analysis must be done in each situation.

It isn't easy, but not impossible for women suffering from ADHD to stop taking their medication. In fact, in a recent article in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of loneliness and family conflict for patients with ADHD. Additionally, the loss of medication can affect the ability to complete job-related tasks and drive safely that are crucial aspects of daily life for many people suffering from ADHD.

She suggests that women who are unsure whether to continue taking medication or stop due to pregnancy educate family members, coworkers and friends about the condition, the impact on daily functioning and the advantages of staying on the current treatment plan. It can also make the woman feel more comfortable when she is struggling with her decision. Some medications can pass through the placenta. If the patient decides not to take her ADHD medication while breastfeeding, it is crucial to be aware that the drug could be passed on to her infant.

Risk of Birth Defects

As the use and use of ADHD drugs to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD) increases the concern over the possible effects of the drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this issue. Researchers utilized two massive data sets to study over 4.3 million pregnancy and determine if the use of stimulant medications increased the risk of birth defects. Researchers discovered that although the risk overall is low, the first trimester ADHD medication exposure was associated with slightly higher risk of certain heart defects, such as ventriculoseptal defect.

The authors of the study could not discover any link between the use of early medications and other congenital anomalies like facial deformities or club feet. The results are in line with previous studies that have shown an increase, but not significant, in the risk of heart malformations in women who started taking ADHD medications prior to the time of the birth of their child. The risk increased in the latter half of pregnancy, when a lot of women stopped taking their medication.

Women who used ADHD medications in the first trimester of their pregnancy were also more likely to undergo caesarean sections, a low Apgar score following delivery, and a baby who needed help breathing at birth. The authors of the study were unable to eliminate selection bias because they limited the study to women without other medical conditions that might have contributed to the findings.

The researchers hope their study will aid in the clinical decisions of doctors who encounter pregnant women. The researchers recommend that while discussing benefits and risks are important, the choice about whether to continue or stop taking medication should be according to the severity of each woman's ADHD symptoms and her needs.

The authors also advise that even though stopping the medication is an alternative, it is not a recommended practice because of the high rate of depression and other mental health issues for women who are expecting or recently post-partum. Additionally, research suggests that women who stop taking their medication will have a difficult transitioning to life without them after the baby is born.

Nursing

It can be overwhelming to become a mom. Women with ADHD who have to deal with their symptoms while attending doctor appointments and getting ready for the arrival of a baby and adjusting to new household routines can experience severe challenges. Therefore, many women elect to continue taking their get adhd medication online medication throughout the pregnancy.

The majority of stimulant medications are absorbed through breast milk in very small amounts, therefore the risk to breastfeeding infant is minimal. The rate of exposure to medication can vary depending upon the dosage and frequency of administration as well as time of day. In addition, individual medications enter the baby's system differently through the gastrointestinal tract as well as breast milk and the impact of this on a newborn isn't yet fully known.

Due to the absence of research, some doctors may recommend stopping stimulant medications during the pregnancy of a woman. This is a difficult decision for the woman who must weigh the advantages of continuing her medication against the potential risks to the fetus. In the meantime, until more information is available, doctors may inquire about pregnant patients whether they have a background of ADHD or if they intend to take medication during the perinatal period.

A growing number of studies have shown that women can continue their ADHD medication while they are pregnant and nursing. In response, a growing number of patients are opting to do this. They have found through consultation with their doctors that the benefits of continuing their current medication outweigh potential risks.

Women with Adhd medication pregnancy who are planning to nurse should seek advice from an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation should also be offered to help women with ADHD understand their symptoms and the underlying disorder Learn about the available treatment options and strengthen existing strategies for managing. This should be a multidisciplinary approach together with obstetricians, GPs and psychiatrists. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and child, as well as monitoring for indicators of deterioration, and, if necessary, adjustments to the medication regimen.

좋아요 0